Sarcoidosis-associated myelopathy: Clinical and MRI phenotypes

Takeaway

  • This is the largest study to date examining clinical and MRI phenotypes in sarcoidosis-associated myelopathy (SAM).

Why this matters

  • Currently diagnosing SAM and differentiating it from clinically similar disorders can be difficult.

  • Improved understanding of the distinct MRI phenotypes of SAM, along with the clinical features, will offer improved diagnosis of the disorder in the future, and may lead to earlier access to treatment.